Cellebrite DI Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Craig Hallum from $23.00 to $24.00. They now have a "buy" rating on the stock.
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $21.00 to $22.00. They now have an "overweight" rating on the stock.
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $17.00 to $21.00. They now have a "buy" rating on the stock.
Cellebrite DI Ltd (CLBT) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]